comparemela.com
  1. Home
  2. Live Updates
  3. Neurona Therapeutics Presents Clinical Case Study from First Human Trial of Regenerative Cell Therapy, NRTX-1001, in Adults with Drug-Resistant Focal Epilepsy : comparemela.com

Neurona Therapeutics Presents Clinical Case Study from First Human Trial of Regenerative Cell Therapy, NRTX-1001, in Adults with Drug-Resistant Focal Epilepsy

Neurona Therapeutics Presents Clinical Case Study from First Human Trial of Regenerative Cell Therapy, NRTX-1001, in Adults with Drug-Resistant Focal Epilepsy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

California ,United States ,Americans ,Coryr Nicholas ,Elizabeth Wolffe ,California Institute For Regenerative Medicine ,Safety Monitoring Board ,Emerging Therapies ,Catherine Priest ,Cellular Technologies ,Data Safety Monitoring Board ,California Institute ,Regenerative Medicine ,Clinical Trial ,Mesial Temporal Lobe Epilepsy ,Media Contacts ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.